Skip to main content

Table 4 Antihypertensive medication prescribed to hypertensive patients

From: Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal

Antihypertensive Drug All patients (n = 205) (%) Patients with target BP <140/90 mmHg (n = 156) (%) Patients with target BP <130/80 mmHg (n = 49) (%) PValue*
Loop diuretics 13.2 11.5 18.4 0.218
   Furosemide 13.2 11.5 18.4  
Thiazide diuretics 66.8 64.1 75.5 0.139
   Altizide 1.0 0.6 2.0  
   Hydrochlorothiazide 50.7 46.8 63.3  
   Indapamide 15.1 16.7 10.2  
Potassium-sparing diuretics 3.9 1.3 12.3 0.003
   Spironolactone 2.9 1.3 8.2  
   Triamterene 1.0 0.0 4.1  
Renin inhibitor 2.0 1.9 2.0 1
   Aliskiren 2.0 1.9 2.0  
Angiotensin-converting enzyme inhibitors 29.8 27.5 36.8 0.221
   Cilazapril 1.0 1.3 0.0  
   Enalapril 11.7 7.7 24.5  
   Imidapril 0.5 0.6 0.0  
   Lisinopril 3.4 3.2 4.1  
   Perindopril 6.8 9.0 0.0  
   Ramipril 5.9 5.1 8.2  
   Trandolapril 0.5 0.6 0.0  
Angiotensin II-receptor antagonists 60.1 58.4 65.3 0.383
   Candesartan 6.3 7.7 2.0  
   Eprosartan 2.0 1.3 4.1  
   Irbesartan 8.8 8.3 10.2  
   Losartan 12.2 13.5 8.2  
   Olmesartan 2.0 2.6 0.0  
   Telmisartan 15.1 13.5 20.4  
   Valsartan 13.7 11.5 20.4  
Calcium channel blockers 39.7 36.4 48.9 0.121
   Amlodipine 21.5 18.6 30.6  
   Felodipine 2.0 1.9 2.0  
   Lercanidipine 3.9 3.8 4.1  
   Nifedipine 5.4 5.1 6.1  
   Nimodipine 0.5 0.6 0.0  
   Nitrendipine 1.0 1.3 0.0  
   Diltiazem 5.4 5.1 6.1  
Beta-blockers 42.6 41.6 45.0 0.689
   Atenolol 5.9 6.4 4.1  
   Bisoprolol 5.9 6.4 4.1  
   Metoprolol 0.5 0.6 0.0  
   Nebivolol 23.9 21.2 32.7  
   Propranolol 0.5 0.6 0.0  
   Carvedilol 5.9 6.4 4.1  
Central alpha-2 agonists 10.8 10.8 10.2 0.888
   Clonidine 0.5 0.6 0.0  
   Methyldopa 0.5 0.6 0.0  
   Rilmenidine 9.8 9.6 10.2  
  1. *P values are for comparison between the two last columns.